John F Mauldin - Net Worth and Insider Trading
John F Mauldin Net Worth
The estimated net worth of John F Mauldin is at least $69,063 dollars as of 2024-11-10. John F Mauldin is the Director of Galectin Therapeutics Inc and owns about 23,021 shares of Galectin Therapeutics Inc (GALT) stock worth over $69,063. Details can be seen in John F Mauldin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John F Mauldin has not made any transactions after 2014-01-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of John F Mauldin
John F Mauldin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John F Mauldin owns 2 companies in total, including AgeX Therapeutics Inc (AGE) , and Galectin Therapeutics Inc (GALT) .
Click here to see the complete history of John F Mauldin’s form 4 insider trades.
Insider Ownership Summary of John F Mauldin
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
AGE | AgeX Therapeutics Inc | 2018-11-27 | director |
GALT | Galectin Therapeutics Inc | 2014-01-02 | director |
John F Mauldin Latest Holdings Summary
John F Mauldin currently owns a total of 1 stock. John F Mauldin owns 23,021 shares of Galectin Therapeutics Inc (GALT) as of January 2, 2014, with a value of $69,063.
Latest Holdings of John F Mauldin
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
GALT | Galectin Therapeutics Inc | 2014-01-02 | 23,021 | 3.00 | 69,063 |
Holding Weightings of John F Mauldin
John F Mauldin Form 4 Trading Tracker
According to the SEC Form 4 filings, John F Mauldin has made a total of 0 transactions in Galectin Therapeutics Inc (GALT) over the past 5 years. The most-recent trade in Galectin Therapeutics Inc is the acquisition of 618 shares on January 2, 2014, which cost John F Mauldin around $4,950.
Insider Trading History of John F Mauldin
- 1
John F Mauldin Trading Performance
GuruFocus tracks the stock performance after each of John F Mauldin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John F Mauldin is 71.94%. GuruFocus also compares John F Mauldin's trading performance to market benchmark return within the same time period. The performance of stocks bought by John F Mauldin within 3 months outperforms 8 times out of 9 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how John F Mauldin's insider trading performs compared to the benchmark.
Performance of John F Mauldin
John F Mauldin Ownership Network
Ownership Network List of John F Mauldin
Ownership Network Relation of John F Mauldin
John F Mauldin Owned Company Details
What does AgeX Therapeutics Inc do?
Who are the key executives at AgeX Therapeutics Inc?
John F Mauldin is the director of AgeX Therapeutics Inc. Other key executives at AgeX Therapeutics Inc include director & 10 percent owner Juvenescence Us Corp. , Chief Financial Officer Park Andrea Eun Jae , and director & Chief Executive Officer Michael D West .
AgeX Therapeutics Inc (AGE) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of AgeX Therapeutics Inc (AGE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AgeX Therapeutics Inc (AGE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
AgeX Therapeutics Inc (AGE)'s detailed insider trading history can be found in Insider Trading Tracker table.
AgeX Therapeutics Inc Insider Transactions
John F Mauldin Mailing Address
Above is the net worth, insider trading, and ownership report for John F Mauldin. You might contact John F Mauldin via mailing address: 3204 Beverly Drive, Dallas Tx 75205.